Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus
AimInvestigate effects of Ebenatide, a novel glucagon-like peptide-1 analogue, on glycemic control and body composition in type 2 diabetes mellitus (T2DM).MethodsThis randomized, prospective, interventional study enrolled 78 subjects (76 finished). Subjects were randomized to either the Ebenatide gr...
Saved in:
| Main Authors: | Cheng-lan Xu, Xiao-cen Kong, Xiao-mei Liu, Xiao-hua Xu, Bing-li Liu, Jian-hua Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1622526/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
by: Xu He, et al.
Published: (2025-01-01) -
Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen
by: Yi-Hsuan Lin, et al.
Published: (2022-12-01) -
Freestyle Libre‐Derived Metrics in Assessing Glycemic Control in Diabetic Dogs
by: Francesca Del Baldo, et al.
Published: (2025-07-01) -
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring
by: Aleksandra Kezić, et al.
Published: (2025-05-01) -
Effects of beinaglutide on visceral fat area and gut microbiota in obesity
by: Tianshui Liu, et al.
Published: (2025-06-01)